268 related articles for article (PubMed ID: 30203070)
1. Result of the 6-min walk test is an independent prognostic factor of surgically treated non-small-cell lung cancer.
Marjanski T; Badocha M; Wnuk D; Dziedzic R; Ostrowski M; Sawicka W; Rzyman W
Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):368-374. PubMed ID: 30203070
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of 6-Min Walk Test to Predict Postoperative Cardiopulmonary Complications in Patients With Non-small Cell Lung Cancer.
Lee H; Kim HK; Kang D; Kong S; Lee JK; Lee G; Shin S; Cho J; Zo JI; Shim YM; Park HY
Chest; 2020 Jun; 157(6):1665-1673. PubMed ID: 31987880
[TBL] [Abstract][Full Text] [Related]
3. Patients who do not reach a distance of 500 m during the 6-min walk test have an increased risk of postoperative complications and prolonged hospital stay after lobectomy.
Marjanski T; Wnuk D; Bosakowski D; Szmuda T; Sawicka W; Rzyman W
Eur J Cardiothorac Surg; 2015 May; 47(5):e213-9. PubMed ID: 25721817
[TBL] [Abstract][Full Text] [Related]
4. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
5. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
Yang CJ; Gu L; Shah SA; Yerokun BA; D'Amico TA; Hartwig MG; Berry MF
Lung Cancer; 2018 Jan; 115():75-83. PubMed ID: 29290266
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of a novel scoring system using inflammatory response biomarkers in non-small cell lung cancer: A retrospective study.
Wang Y; Hu X; Xu W; Wang H; Huang Y; Che G
Thorac Cancer; 2019 Jun; 10(6):1402-1411. PubMed ID: 31104359
[TBL] [Abstract][Full Text] [Related]
10. The 6-min walk test in the functional evaluation of patients with lung cancer qualified for lobectomy.
Wesolowski S; Orlowski TM; Kram M
Interact Cardiovasc Thorac Surg; 2020 Apr; 30(4):559-564. PubMed ID: 32068846
[TBL] [Abstract][Full Text] [Related]
11. Additional pulmonary resections after pneumonectomy: actual long-term survival and functional results.
Grodzki T; Alchimowicz J; Kozak A; Kubisa B; Pieróg J; Wójcik J; Bielewicz M; Witkowska D
Eur J Cardiothorac Surg; 2008 Sep; 34(3):493-8. PubMed ID: 18583143
[TBL] [Abstract][Full Text] [Related]
12. Pneumonectomy for stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival.
Alexiou C; Beggs D; Onyeaka P; Kotidis K; Ghosh S; Beggs L; Hopkinson DN; Duffy JP; Morgan WE; Rocco G
Ann Thorac Surg; 2003 Oct; 76(4):1023-8. PubMed ID: 14529978
[TBL] [Abstract][Full Text] [Related]
13. Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer.
Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Taniguchi D; Nagayasu T
Eur J Cardiothorac Surg; 2015 Apr; 47(4):e140-5. PubMed ID: 25548132
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of prognostic factors and efficacy of surgical treatment for non-small cell lung cancer: department of surgery NTLDRI (1998-1999)].
Chabowski M; Orłowski TM; Rabczenko D
Pneumonol Alergol Pol; 2008; 76(1):1-10. PubMed ID: 18283649
[TBL] [Abstract][Full Text] [Related]
15. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
[TBL] [Abstract][Full Text] [Related]
16. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary middle lobectomy for non-small-cell lung cancer: effectiveness and prognostic implications.
Mazza F; Ferrari E; Maineri P; Venturino M; Dozin B; Ratto GB
Eur J Cardiothorac Surg; 2015 Dec; 48(6):e117-23. PubMed ID: 26374866
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer].
Gao YS; Xing XZ; Shao K; Feng XL; He J
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):134-7. PubMed ID: 18646698
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S
Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
